Adiponectin and Adiponectin Receptors in Atherosclerosis
Endocrine Reviews · 10.01.2025 · 46 (1) · 1-25
DOI: 10.1210/endrev/bnae021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 06.08.2024. Verfasst von Ioanna Gianopoulos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Medicine, Department of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, McGill Uni…. Hauptthemen laut MEDLINE: Receptors, Adiponectin, Adiponectin, Atherosclerosis, Macrophages. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 314 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR, Heart & Stroke Foundation of Canada, Fonds de recherche du Québec-Santé.
Abstract (Originalsprache)
Adiponectin is an abundantly secreted hormone that communicates information between the adipose tissue, and the immune and cardiovascular systems. In metabolically healthy individuals, adiponectin is usually found at high levels and helps improve insulin responsiveness of peripheral tissues, glucose tolerance, and fatty acid oxidation. Beyond its metabolic functions in insulin-sensitive tissues, adiponectin plays a prominent role in attenuating the development of atherosclerotic plaques, partially through regulating macrophage-mediated responses. In this context, adiponectin binds to its receptors, adiponectin receptor 1 (AdipoR1) and AdipoR2 on the cell surface of macrophages to activate a downstream signaling cascade and induce specific atheroprotective functions. Notably, macrophages modulate the stability of the plaque through their ability to switch between proinflammatory responders, and anti-inflammatory proresolving mediators. Traditionally, the extremes of the macrophage polarization spectrum span from M1 proinflammatory and M2 anti-inflammatory phenotypes. Previous evidence has demonstrated that the adiponectin-AdipoR pathway influences M1-M2 macrophage polarization; adiponectin promotes a shift toward an M2-like state, whereas AdipoR1- and AdipoR2-specific contributions are more nuanced. To explore these concepts in depth, we discuss in this review the effect of adiponectin and AdipoR1/R2 on 1) metabolic and immune responses, and 2) M1-M2 macrophage polarization, including their ability to attenuate atherosclerotic plaque inflammation, and their potential as therapeutic targets for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Experimental Medicine, Department of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec H4A 3J1, Canada.
- Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
- Section of Endocrinology, Diabetes and Metabolism, Boston VA Healthcare System, Boston, MA 02130, USA.
- Division of Internal Medicine, Department of Medicine, Faculty of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec H4A 3J1, Canada.
ORCID-Profile: Stella S Daskalopoulou
Förderung
- CIHR
- Heart & Stroke Foundation of Canada
- Fonds de recherche du Québec-Santé
- Merck
- Massachusetts Life Sciences Center
- Boehringer-Ingelheim
- Canadian Institutes of Health Research
Zitieren
APA
Gianopoulos, I., Mantzoros, C. S., & Daskalopoulou, S. S. (2025). Adiponectin and Adiponectin Receptors in Atherosclerosis. Endocrine Reviews, 46(1), 1-25. https://doi.org/10.1210/endrev/bnae021
Vancouver
Gianopoulos I, Mantzoros CS, Daskalopoulou SS. Adiponectin and Adiponectin Receptors in Atherosclerosis. Endocrine Reviews. 2025;46(1):1-25. doi:10.1210/endrev/bnae021
BibTeX
@article{Gianopoulos2025,
author = {Gianopoulos, Ioanna and Mantzoros, Christos S and Daskalopoulou, Stella S},
title = {Adiponectin and Adiponectin Receptors in Atherosclerosis},
journal = {Endocrine Reviews},
year = {2025},
volume = {46},
number = {1},
pages = {1--25},
doi = {10.1210/endrev/bnae021}
}
EUVIMED